- Service Name
Wheeler Bio
- Industry
Biotechnology, Contract Development and Manufacturing Organization (CDMO), Biomanufacturing, Biologics Development
- Main Value Proposition
Wheeler Bio offers a novel, modular approach that enhances the speed and efficiency of biologics development, providing budgetary transparency and timeline certainty.
- Description
Wheeler Bio is a biomanufacturing company that specializes in cell line development and biologics contract development and manufacturing organization (CDMO) services. The company focuses on accelerating the transition from discovery to clinical supply for biopharma innovators.
- Key Features
Modular CMC approach for streamlined development; Best-in-class mammalian cell line and process development; GLP Tox material supply; Efficient cGMP clinical supply
- Use Cases
Wheeler Bio is most valuable for biopharma companies looking to expedite their development processes, particularly in the areas of monoclonal antibody development and recombinant protein expression.
- Competitive advantages
Accelerated transition from discovery to clinical supply; High level of collaboration and engagement with clients; State-of-the-art facilities located in an innovation hub
- Strengths
Wheeler Bio's strengths lie in its innovative approach to biologics development, its experienced team of CMC experts, and its commitment to providing high-quality, efficient services.
- Positioning
Wheeler Bio positions itself as a forward-thinking CDMO that leverages a modular approach to enhance the speed and quality of biologics development.
- Audience
The target users include biopharma companies, biotech innovators, and research organizations that require efficient and reliable development services for their therapeutic products.
- CTA
Connect with our team today to learn more about how Wheeler can add value to your program.
- Tags
Biologics
CDMO
Cell Line Development
Modular CMC
- Tagline
Accelerating Discovery to Development for Biopharma
- Tone of Voice
Professional, collaborative, innovative
- Differentiation
Wheeler Bio's unique modular CMC platform allows for flexible, standalone development services that can be tailored to the specific needs of biopharma innovators, setting it apart from traditional CDMO models.
- Brand Positioning
Wheeler Bio identifies itself as a collaborative partner in the biopharma industry, focused on driving clinical impact through innovative solutions and expert guidance.
- Founded
2020-01-01
- Founders
Jesse McCool